Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRDN | AMGN | VRTX | BMY | GILD |
| Company | Viridian Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 21.72 | 291.50 | 478.56 | 58.16 | 91.71 |
| High | 21.77 | 291.50 | 479.94 | 58.36 | 91.99 |
| Low | 19.65 | 280.05 | 458.10 | 56.42 | 89.31 |
| Last | 20.13 | 281.91 | 460.51 | 56.72 | 90.00 |
| Change | -1.51 | -14.02 | -23.45 | -1.78 | -2.11 |
| % Change | -6.98% | -4.74% | -4.85% | -3.04% | -2.29% |
| Volume | 542,347 | 1,584,109 | 693,639 | 6,443,748 | 2,873,296 |
| 20-Day Average Volume | 994,839 | 2,310,952 | 1,094,750 | 10,766,139 | 6,879,942 |
| Previous Close | 21.64 | 295.93 | 483.96 | 58.50 | 92.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 23.17 | 313.89 | 482.89 | 54.94 | 90.74 |
| 20-Day Raw Stochastic | 1.36% | 1.76% | 3.39% | 53.51% | 29.17% |
| 20-Day Relative Strength | 41.06% | 28.17% | 43.28% | 58.25% | 52.91% |
| Weighted Alpha | -7.18 | -1.70 | +22.57 | +20.14 | +25.82 |
| Today's Opinion | 56% Buy | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 64% Buy | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Last Month's Opinion | 88% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.94% since 11/08/24 | -13.12% since 11/08/24 | -10.90% since 11/08/24 | +4.86% since 11/08/24 | -7.34% since 11/08/24 |
| Low | 19.83 on 11/15/24 | 281.78 on 11/15/24 | 458.34 on 11/15/24 | 56.42 on 11/15/24 | 89.44 on 11/15/24 |
| High | 27.20 on 11/12/24 | 327.58 on 11/11/24 | 518.35 on 11/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | -17.10% since 10/15/24 | -13.07% since 10/15/24 | -4.93% since 10/15/24 | +7.60% since 10/15/24 | +4.26% since 10/15/24 |
| Low | 19.83 on 11/15/24 | 281.78 on 11/15/24 | 458.34 on 11/15/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 27.20 on 11/12/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +33.58% since 08/15/24 | -13.15% since 08/15/24 | -2.45% since 08/15/24 | +15.60% since 08/15/24 | +20.37% since 08/15/24 |
| Low | 13.20 on 09/05/24 | 281.78 on 11/15/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 27.20 on 11/12/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +39.66% since 05/15/24 | -11.42% since 05/15/24 | +5.24% since 05/15/24 | +27.43% since 05/15/24 | +33.53% since 05/15/24 |
| Low | 11.40 on 06/04/24 | 281.78 on 11/15/24 | 432.22 on 05/16/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 27.20 on 11/12/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,714,169 | 159,072,144 | 124,633,728 | 118,648,352 | 114,793,560 |
| Shares Outstanding, K | 79,213 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 310,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -237,730,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 70,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -64,990,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.10 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.15 on 11/12/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.68 | 0.00 | 49.92 | 20.91 |